Opto Circuits climbs on launch of first Sirolimus drug Myiris.com Opto Circuits (India) surged on Tuesday after Opto Eurocor Healthcare (OEHL), a subsidiary of the company, launched its first Sirolimus Drug Eluting Stent (DES), E-MAGIC Plus on receipt of Drug Controller General of India (DCGI) license to sell and ... Opto Circuits' arm launches new drug eluting stent Opto Circuits receives DCGI license for sale of sirolimus drug eluting stent ... Opto Circuits gets DCGI nod for heart device |
